Impact of Tranexamic Acid on Chondrocytes and Osteogenically Differentiated Human Mesenchymal Stromal Cells (hMSCs) In Vitro
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of Clinical Medicine 2020, 9(12), 3880; https://doi.org/10.3390/jcm9123880
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2021
- Creator
-
Wagenbrenner, Mike
Heinz, Tizian
Horas, Konstantin
Jakuscheit, Axel
Arnholdt, Joerg
Mayer-Wagner, Susanne
Rudert, Maximilian
Holzapfel, Boris M.
Weißenberger, Manuel
- DOI
-
10.3390/jcm9123880
- URN
-
urn:nbn:de:bvb:20-opus-219410
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wagenbrenner, Mike
- Heinz, Tizian
- Horas, Konstantin
- Jakuscheit, Axel
- Arnholdt, Joerg
- Mayer-Wagner, Susanne
- Rudert, Maximilian
- Holzapfel, Boris M.
- Weißenberger, Manuel
- Universität Würzburg
Time of origin
- 2021
Other Objects (12)
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee
Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility
Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Response of human chondrocytes and mesenchymal stromal cells to a decellularized human dermis
Connexin 43 regulates intercellular mitochondrial transfer from human mesenchymal stromal cells to chondrocytes
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
The role of MSCs and CAR-MSCs in cellular immunotherapy
MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee
Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility
Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Response of human chondrocytes and mesenchymal stromal cells to a decellularized human dermis
Connexin 43 regulates intercellular mitochondrial transfer from human mesenchymal stromal cells to chondrocytes
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
The role of MSCs and CAR-MSCs in cellular immunotherapy
MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee
Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility
Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Response of human chondrocytes and mesenchymal stromal cells to a decellularized human dermis
Connexin 43 regulates intercellular mitochondrial transfer from human mesenchymal stromal cells to chondrocytes
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
The role of MSCs and CAR-MSCs in cellular immunotherapy